1-248273615-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004695.2(OR2T33):āc.200T>Cā(p.Met67Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,613,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004695.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2T33 | NM_001004695.2 | c.200T>C | p.Met67Thr | missense_variant | 2/2 | ENST00000641220.1 | NP_001004695.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2T33 | ENST00000641220.1 | c.200T>C | p.Met67Thr | missense_variant | 2/2 | NM_001004695.2 | ENSP00000493437.1 | |||
OR2T33 | ENST00000318021.4 | c.200T>C | p.Met67Thr | missense_variant | 1/1 | 6 | ENSP00000324687.2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152078Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251012Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135658
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461388Hom.: 0 Cov.: 141 AF XY: 0.0000151 AC XY: 11AN XY: 727004
GnomAD4 genome AF: 0.000210 AC: 32AN: 152196Hom.: 0 Cov.: 34 AF XY: 0.000269 AC XY: 20AN XY: 74436
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.200T>C (p.M67T) alteration is located in exon 1 (coding exon 1) of the OR2T33 gene. This alteration results from a T to C substitution at nucleotide position 200, causing the methionine (M) at amino acid position 67 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at